As world leaders in scintigraphic imaging of drug delivery systems, Bio-Images offers a unique clinical research service to the global pharmaceutical and healthcare industry.
Gamma scintigraphy allows non-invasive, quantitative assessment of the behaviour of oral, nasal, pulmonary and ophthalmic formulations in man. The data produced allows informed decision making at the crucial early stages of the development pipeline, cutting costs and reducing the time to market.
As part of the Bio-Images Group, we work closely with our sister company, Drug Delivery International, who provide expertise in formulation development. With our imaging experience working alongside DDi's formulation expertise, the Bio-Images Group offers a unique integrated appropach to providing practical and cost effective formulation solutions in a timely manner.
Follow the linkedin group, Gamma Scintigraphy, for more discussions on the role of scintigraphy in pharmaceutical development.
Specialties
Gamma scintigraphy, Clinical trials, Drug delivery
New hires at Bio-Images Research
-
Director, Regulatory Affairs
Came from...
Bio-Images Research Ltd., Clinical Research Pharmacist
